Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
IMNP immunepharmaceuticals een pareltje!
Volgen
IMMUNE PHARMA BUDS of Ceplene, new attempt in the US - CEO (Direct) 2016-12-08 17:27 STOCKHOLM (AFX) Immune Pharmaceuticals buds of cancer drug Ceplene and form a new company that will make a new attempt to get the drug on the US market. It says immunes CEO Daniel Teper to the news agency Direkt before the company's webcast R & D update at 17:00 CET on Thursday, Swedish time. The company's shares rose yesterday by more than 70 percent without any news had been presented. Rate increase is according to CEO on selling pressure in immunes shares declined and investors look to the dormant project Ceplene alive again. "We have been going around and met with investors in recent months, and people are now looking more to the fundamentals of the company than before. Research and development projects are developing rapidly and now bertilimumab our only focus," says Daniel Teper. Ceplene is an immune stimulant drugs developed against acute myeloid leukemia and is approved in Europe. 2012 out-licensed the drug to the Swedish Meda, which this year was bought by Mylan. Attempts to launch the drug in the US market were up after the FDA demanded additional Phase 3 study, but now the tests will be taken up again. During the evening will update Daniel Teper talk more about the spin-off of Ceplene in the new company which Immune Pharmaceutical become the largest shareholder. New money should be brought in for the continued development, how much is yet to be decided. What makes that Ceplene will have better chances of reaching the United States now? "We published a new study with Ceplene early in 2016 that showed positive results in progression-free survival. The development includes testing of biomarker and the effect can be seen after six weeks, which is advantageous in a health economic perspective," said Daniel Teper and continues: "In addition, we will in 2017 launch a phase 3 clinical study in which we have collaborated with the FDA on the study design," he says. Ceplene reaches the US market, sales may exceed $ 200 million, according to Daniel Teper. Regarding bertilimumab, which is the only substance that remains in immunes portfolio in the future, two ongoing studies in various indications in which results are expected in 2017. The company took in November, up $ 11 million from existing investors and will in 2017 examine more indications of bertilimumab. Parallel to the development of the company, talks with "several potential partners," according to Daniel Teper. Probably covering a partnership all the indications bertilimumab developed within instead of signing contracts for the various disease area, he says. Speculation in the market raises the question whether Pfizer is getting ready to devour the research company, but Daniel Teper would not comment on market rumors. However, he certifies that the company has been in dialogue with several major pharmaceutical companies, including Pfizer, but it will not affect the information in tonight's R & D update. Onderstaand artikel is via Google vanuit het Zweeds vertaald. Bron:https://www.avanza.se/placera/telegram/2016/12/08/immune-pharma-knoppar-av-ceplene-nytt-forsok-i-usa-vd.html
Dank je. Ik heb er nog vertrouwen in. Komt goed met dit aandeel, gewoon geduld hebben.
Deze staat op uitbreken staat nu nog erg laag. Mast Therapeutics Inc (MSTX :NYSE MKT) Real Time Quote | Source: NYSE MKT + WATCHLIST 0.1221 USD
+14% in de pre market. je zou zowaar gaan geloven in een nieuwe rally (edit) met een schamelijke 500 stuks helaas. damn;-)
Ik hoopte wel op een leuke rally, maar 14% in de plus? Hij begon volgens mij al in de min. 0,104 na een slot van 0,109 gisteren. Ze zijn flink gekelderd stormvogel.
dakdekker schreef op 13 december 2016 19:10 :
Ik hoopte wel op een leuke rally, maar 14% in de plus? Hij begon volgens mij al in de min. 0,104 na een slot van 0,109 gisteren.
Ze zijn flink gekelderd stormvogel.
Dit ging over IMNP;-) hoop niet dat die naar de 0,10 gaan in iedergeval
Hoop het ook voor je en voor iedereen die er in zit, stond vandaag voorbeurs ook in de plus +2,4% op 0,2048 en is richting de 0,18 gezakt. De 0,10 raakt langzamerhand toch in zicht als dat zo doortrekt. Het lijkt deze week echt wel zeuren met de biootjes.
Gister leuke rally.(even) Had de helft te koop staan op 0,24 helaas net niet geraakt. als ik hier maar geen spijt van krijg...
Er is iets aan de hand of er komt iets aan denken de meesten, anders is er niet zo'n hoog volume. Ik zeg, ff vasthouden nog.
laten we het (wederom) hopen. Ik zit er eigenlijk met teveel stukken in op dit moment voor het leuke
Transgenomic Inc (TBIO:NASDAQ) 1.41 USD + 0.29 ( + 25.89 %) 38,854,463 Volcharts.stocktwits.com/production/stre...
Is er iets aan de hand bij IMNP? Premarket high op 0,35 geweest ...... iemand erg gretig geweest om ze te krijgen.www.nasdaq.com/symbol/imnp/premarket
Nee, die prijzen krijg je als er erg weinig stukken zijn die hoog ingezet worden. Meestal gebeurt het dat deze ook weer net voor de beurs open gaat weer teruggetrokken worden.
immunepharmaceuticals.investorroom.co... Denk dat we de bodem van 16 dollarcent nu wel achter ons hebben gelaten. Koers beweegt al een tijdje tussen de 20 - 22 cent.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
874,79
+0,96%
EUR/USD
1,0707
+0,52%
FTSE 100
8.044,81
+0,26%
Germany40^
18.165,90
+1,71%
Gold spot
2.325,80
-0,06%
NY-Nasdaq Composite
15.451,31
+1,11%
Stijgers
Dalers